Chongqing Pharscin Pharmaceutical Co., Ltd. (002907) Stock Recommendation | Score, Valuation, Technicals & Financial Trend

Score

Click here to find our call on this stock

Strong Sell

Sell

Hold

Buy

Strong Buy

MarketsMojo — Loved in India, Now Global

The power of Mojo is now in 29 countries. Explore global equities with the same cutting-edge features you love.Unlock 29 Markets

Comparison

Company

Score

Quality

Valuation

Financial

Technical

Chongqing Pharscin Pharmaceutical Co., Ltd.

Why is Chongqing Pharscin Pharmaceutical Co., Ltd. ?

Poor long term growth as Net Sales has grown by an annual rate of -0.57% and Operating profit at -15.01% over the last 5 years

Flat results in Mar 25

INTEREST(9M) At CNY 0.34 MM has Grown at 11.06%

With ROE of 4.51%, it has a expensive valuation with a 2.78 Price to Book Value

Over the past year, while the stock has generated a return of 15.79%, its profits have risen by 117.1% ; the PEG ratio of the company is 0.5
At the current price, the company has a high dividend yield of 0.5

Real-Time Research Report

Verdict Report

How much should you sell?

All quantity irrespective of whether you are making profits or losses

(If sector exposure > 30%, please use optimiser tool to see which are the best stocks to hold in Pharmaceuticals & Biotechnology)

When to re-enter? - We will constantly monitor the company and review our call based on new data

Is Chongqing Pharscin Pharmaceutical Co., Ltd. for you?

High Risk, High Return

Absolute

Risk Adjusted

Volatility

Chongqing Pharscin Pharmaceutical Co., Ltd.

12.71%

0.64

42.14%

China Shanghai Composite

14.77%

1.01

15.10%

Quality

Management Risk

Growth

Capital Structure

Quality grade scale :

Below Average, Average, Good, Excellent

Quality key factors

Factor

Value

Sales Growth (5y)

-0.57%

EBIT Growth (5y)

-15.01%

EBIT to Interest (avg)

23.95

Debt to EBITDA (avg)

Net Debt to Equity (avg)

-0.32

Sales to Capital Employed (avg)

0.45

Tax Ratio

17.45%

Dividend Payout Ratio

46.27%

Pledged Shares

Institutional Holding

ROCE (avg)

7.58%

ROE (avg)

5.89%

Valuation

Valuation Scorecard

Valuation grade scale :

Very Risky, Risky, Very Expensive, Expensive, Fair, Attractive, Very Attractive

Valuation Key Factors

Factor

Value

P/E Ratio

Industry P/E

Price to Book Value

2.78

EV to EBIT

64.65

EV to EBITDA

27.39

EV to Capital Employed

3.68

EV to Sales

5.23

PEG Ratio

0.52

Dividend Yield

0.52%

ROCE (Latest)

5.69%

ROE (Latest)

4.51%

Technicals

Technical key factors

Indicator

Weekly

Monthly

MACD

Mildly Bearish

Bullish

RSI

No Signal

Bollinger Bands

Bearish

Mildly Bullish

Moving Averages

Mildly Bullish (Daily)

KST

Bearish

Bullish

Dow Theory

Mildly Bearish

Mildly Bullish

OBV

Mildly Bullish

No Trend

Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish Turned

Technical Movement

Analyse All Technical Factors

Financial Trend

Financial Trend Scorecard

Financial Trend scale:

Very Negative, Negative, Flat, Positive, Very Positive, Outstanding

20What is working for the Company

OPERATING CASH FLOW(Y)

Highest at CNY 179.85 MM

NET PROFIT(Q)

At CNY 39.97 MM has Grown at 123.38%

RAW MATERIAL COST(Y)

Fallen by -3.01% (YoY

CASH AND EQV(HY)

Highest at CNY 1,155.09 MM

DEBT-EQUITY RATIO (HY)

Lowest at -32.19 %

INVENTORY TURNOVER RATIO(HY)

Highest at 2.73%

NET SALES(Q)

At CNY 236.39 MM has Grown at 23.97%

PRE-TAX PROFIT(Q)

Highest at CNY 50.21 MM

-2What is not working for the Company

INTEREST(9M)

At CNY 0.34 MM has Grown at 11.06%

Here's what is working for Chongqing Pharscin Pharmaceutical Co., Ltd.

Operating Cash Flow

Highest at CNY 179.85 MM and Grown

In each year in the last three years

MOJO Watch

The company has generated higher cash revenues from business operations

Operating Cash Flows (CNY MM)

Pre-Tax Profit

At CNY 50.21 MM has Grown at 115.82%

over average net sales of the previous four periods of CNY 23.26 MM

MOJO Watch

Near term Pre-Tax Profit trend is very positive

Pre-Tax Profit (CNY MM)

Net Profit

At CNY 39.97 MM has Grown at 123.38%

over average net sales of the previous four periods of CNY 17.89 MM

MOJO Watch

Near term Net Profit trend is very positive

Net Profit (CNY MM)

Net Sales

Highest at CNY 236.39 MM

in the last five periods

MOJO Watch

Near term sales trend is positive

Net Sales (CNY MM)

Net Sales

At CNY 236.39 MM has Grown at 23.97%

over average net sales of the previous four periods of CNY 190.68 MM

MOJO Watch

Near term sales trend is positive

Net Sales (CNY MM)

Pre-Tax Profit

Highest at CNY 50.21 MM

in the last five periods

MOJO Watch

Near term Pre-Tax Profit trend is positive

Pre-Tax Profit (CNY MM)

Cash and Eqv

Highest at CNY 1,155.09 MM

in the last six Semi-Annual periods

MOJO Watch

Short Term liquidity is improving

Cash and Cash Equivalents

Debt-Equity Ratio

Lowest at -32.19 %

in the last five Semi-Annual periods

MOJO Watch

The company has been reducing its borrowing as compared to equity capital

Debt-Equity Ratio

Inventory Turnover Ratio

Highest at 2.73%

in the last five Semi-Annual periods

MOJO Watch

Company has been able to sell its inventory faster

Inventory Turnover Ratio

Raw Material Cost

Fallen by -3.01% (YoY)

MOJO Watch

The company's ability to pass on the cost of raw materials to customers has improved; this may lead to a rise in profit margin

Raw Material Cost as a percentage of Sales

Here's what is not working for Chongqing Pharscin Pharmaceutical Co., Ltd.

Interest

At CNY 0.34 MM has Grown at 11.06%

over previous Semi-Annual period

MOJO Watch

Rising interest cost signifies increased borrowings

Interest Paid (CNY MM)